Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Holders of 5% or more of VTYX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ventyx Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 13G/A | 8.30%5.90M shares | +2.10 ppfrom 6.20% | Jan 29, 20252 filings | Aug 14, 2025 | SEC |
| NSV Investments I, L.P. | 13D/A | 7.60%5.43M shares | – | Mar 12, 20251 filing | Mar 12, 2025 | SEC |
| Mohan Raju | 13D | 6.00%4.38M shares | New | Nov 26, 20251 filing | Nov 26, 2025 | SEC |
| NSV Partners III LP | 13D/A | 5.70%4.09M shares | – | Apr 1, 20251 filing | Apr 1, 2025 | SEC |
| Affinity Asset Advisors, LLC | 13G | 5.70%4.06M shares | New | May 30, 20251 filing | May 30, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Ventyx Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 26, 20257:28 PM ET | Mohan Raju | 13D | 6.00%4.38M shares | New | Nov 26, 2025 | SEC |
| Aug 14, 20254:58 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 8.30%5.90M shares | +2.10 ppfrom 6.20% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 1.90%1.35M shares | –Below 5% | Jun 30, 2025 | SEC |
| May 30, 20257:01 PM ET | Affinity Asset Advisors, LLCand 1 other | 13G | 5.70%4.06M shares | New | May 22, 2025 | SEC |
| May 15, 20255:29 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 2.00%1.41M shares | –Below 5% | Mar 31, 2025 | SEC |
| May 15, 20251:10 PM ET | Bank of America Corp | 13G/A | 1.40%1.02M shares | −5.10 ppfrom 6.50%Below 5% | Mar 31, 2025 | SEC |
| Apr 8, 20253:14 PM ET | Sio Capital Management, LLC | 13G/A | 3.63%2.58M shares | −2.09 ppfrom 5.72%Below 5% | Mar 31, 2025 | SEC |
| Apr 1, 20259:40 PM ET | NSV Partners III LPand 2 others | 13D/A | 5.70%4.09M shares | – | Mar 28, 2025 | SEC |
| Mar 12, 20254:05 PM ET | NSV Investments I, L.P.and 3 others | 13D/A | 7.60%5.43M shares | – | Mar 10, 2025 | SEC |
| Feb 14, 20256:09 PM ET | Bank of America Corp | 13G | 6.50%4.62M shares | New | Dec 31, 2024 | SEC |
| Feb 13, 20258:59 AM ET | Flynn James Eand 3 others | 13G/A | 0.76%534.7K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 10, 202512:59 PM ET | Sio Capital Management, LLC | 13G | 5.72%4.05M shares | New | Dec 31, 2024 | SEC |
| Jan 29, 20256:58 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.20%4.40M shares | New | Jan 22, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ventyx Biosciences, Inc. shares.
No Form 144 notices for Ventyx Biosciences, Inc. are on file.